Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Acer Therapeutics - 19 Year Stock Price History | ACER

Historical daily share price chart and data for Acer Therapeutics since 2004 adjusted for splits and dividends. The latest closing stock price for Acer Therapeutics as of November 08, 2023 is 0.90.
  • The all-time high Acer Therapeutics stock closing price was 745597.87 on April 14, 2004.
  • The Acer Therapeutics 52-week high stock price is 1.76, which is 95.6% above the current share price.
  • The Acer Therapeutics 52-week low stock price is 0.55, which is 38.9% below the current share price.
  • The average Acer Therapeutics stock price for the last 52 weeks is 0.83.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Acer Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2023 1.1708 2.6200 3.0500 0.5651 0.9000 -64.14%
2022 1.9134 2.3500 4.1500 1.1300 2.5100 10.09%
2021 2.7764 2.5400 4.3900 1.8800 2.2800 -12.98%
2020 3.0987 3.7900 5.8550 1.1800 2.6200 -34.66%
2019 12.0854 21.4500 26.8600 1.9500 4.0100 -80.07%
2018 21.7936 14.8100 32.8300 14.8100 20.1200 45.27%
2017 10.5805 9.7342 19.3500 5.9026 13.8500 45.37%
2016 27.7358 27.7528 48.5674 5.6955 9.5271 -66.78%
2015 41.5696 63.6161 75.3799 25.1639 28.6796 -51.92%
2014 117.6252 154.9187 179.7719 59.2336 59.6478 -60.44%
2013 147.6719 96.0993 260.9593 96.0993 150.7765 59.99%
2012 211.3836 314.8080 361.2007 92.7772 94.2436 -69.42%
2011 518.8163 503.6928 927.8551 298.2391 308.1805 -36.73%
2010 569.6358 659.4399 954.3653 347.9457 487.1239 -22.63%
2009 405.7804 53.0203 1875.5929 53.0203 629.6160 900.00%
2008 382.6112 722.4015 1139.9363 29.8239 62.9616 -92.18%
2007 1450.1348 1988.2610 1988.2610 712.4602 805.2457 -59.97%
2006 2187.7795 1888.8479 3346.9060 1458.0580 2011.4574 1.17%
2005 10828.1981 21208.1171 28829.7841 1822.5726 1988.2610 -90.62%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.016B $0.001B
Acer Therapeutics Inc. is a pharmaceutical company. It develops therapies for the treatment of ultra-rare diseases with critical unmet medical need. The company's product pipeline consists of Edsivo (TM) and ACER-001 which are in clinical stage. Acer Therapeutics Inc., formerly known as Opexa Therapeutics, Inc., is based in Cambridge, United States.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $70.141B 28.83
Chugai Pharmaceutical (CHGCY) Japan $51.291B 22.93
Takeda Pharmaceutical (TAK) Japan $41.364B 6.70
Merck (MKGAF) Germany $21.368B 20.16
Astellas Pharma (ALPMY) Japan $17.264B 27.26
Sandoz Group AG (SDZNY) Switzerland $14.500B 0.00
Shionogi (SGIOY) Japan $14.029B 12.14
Neurocrine Biosciences (NBIX) United States $13.708B 56.93
United Therapeutics (UTHR) United States $11.103B 11.89
Catalent (CTLT) United States $10.098B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.639B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.768B 6.86
Ionis Pharmaceuticals (IONS) United States $6.098B 0.00
Revolution Medicines (RVMD) United States $5.819B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $4.918B 0.00
Alpine Immune Sciences (ALPN) United States $4.236B 0.00
Madrigal Pharmaceuticals (MDGL) United States $3.868B 0.00
Crinetics Pharmaceuticals (CRNX) United States $2.943B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.710B 0.00
Summit Therapeutics (SMMT) United States $2.491B 0.00
Indivior (INDV) United States $2.378B 11.27
Corcept Therapeutics (CORT) United States $2.312B 23.38
Dyne Therapeutics (DYN) United States $2.042B 0.00
PTC Therapeutics (PTCT) United States $1.953B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.914B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.840B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.816B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.811B 10.73
Evotec AG (EVO) Germany $1.807B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.732B 17.90
Avadel Pharmaceuticals (AVDL) Ireland $1.614B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.597B 27.95
Ardelyx (ARDX) United States $1.468B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.265B 11.88
Soleno Therapeutics (SLNO) United States $1.248B 0.00
4D Molecular Therapeutics (FDMT) United States $1.204B 0.00
Pacira BioSciences (PCRX) United States $1.186B 11.81
Xencor (XNCR) United States $1.185B 0.00
Collegium Pharmaceutical (COLL) United States $1.172B 7.21
Cronos Group (CRON) Canada $0.955B 0.00
Cassava Sciences (SAVA) United States $0.940B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.896B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.858B 0.00
USANA Health Sciences (USNA) United States $0.830B 13.07
Sage Therapeutics (SAGE) United States $0.817B 0.00
Relay Therapeutics (RLAY) United States $0.815B 0.00
Enliven Therapeutics (ELVN) United States $0.785B 0.00
ARS Pharmaceuticals (SPRY) United States $0.781B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.704B 0.00
Ocular Therapeutix (OCUL) United States $0.650B 0.00
Silence Therapeutics (SLN) United Kingdom $0.647B 0.00
ProKidney (PROK) United States $0.622B 0.00
Savara (SVRA) United States $0.615B 0.00
Siga Technologies (SIGA) United States $0.614B 9.09
Calliditas Therapeutics AB (CALT) Sweden $0.579B 0.00
Lyell Immunopharma (LYEL) United States $0.561B 0.00
Verve Therapeutics (VERV) United States $0.520B 0.00
OmniAb (OABI) United States $0.519B 0.00
Altimmune (ALT) United States $0.510B 0.00
Exscientia (EXAI) United Kingdom $0.482B 0.00
Korro Bio (KRRO) United States $0.470B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.444B 0.00
KalVista Pharmaceuticals (KALV) United States $0.443B 0.00
Tourmaline Bio (TRML) United States $0.410B 0.00
Larimar Therapeutics (LRMR) United States $0.404B 0.00
Lexeo Therapeutics (LXEO) United States $0.401B 0.00
Heron Therapeutics (HRTX) United States $0.383B 0.00
Esperion Therapeutics (ESPR) United States $0.377B 0.00
Nature's Sunshine Products (NATR) United States $0.365B 20.44
Harrow (HROW) United States $0.354B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.352B 0.00
Bioventus (BVS) United States $0.322B 0.00
Fractyl Health (GUTS) United States $0.322B 0.00
Lyra Therapeutics (LYRA) United States $0.309B 0.00
Organogenesis (ORGO) United States $0.302B 57.12
Aquestive Therapeutics (AQST) United States $0.288B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.282B 0.00
Nanobiotix S.A (NBTX) France $0.279B 0.00
Akebia Therapeutics (AKBA) United States $0.278B 0.00
ESSA Pharma (EPIX) Canada $0.271B 0.00
Black Diamond Therapeutics (BDTX) United States $0.268B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.264B 0.00
Metagenomi (MGX) United States $0.253B 0.00
Xeris Biopharma Holdings (XERS) United States $0.252B 0.00
Pyxis Oncology (PYXS) United States $0.250B 0.00
Adherex Technologies (FENC) United States $0.248B 0.00
Nektar Therapeutics (NKTR) United States $0.242B 0.00
Aldeyra Therapeutics (ALDX) United States $0.234B 0.00
Conduit Pharmaceuticals (CDT) United States $0.226B 0.00
Foghorn Therapeutics (FHTX) United States $0.223B 0.00
Prelude Therapeutics (PRLD) United States $0.222B 0.00
Galectin Therapeutics (GALT) United States $0.217B 0.00
Avita Medical (RCEL) United States $0.214B 0.00
Innate Pharma SA (IPHYF) France $0.213B 0.00
Century Therapeutics (IPSC) United States $0.204B 0.00
Telomir Pharmaceuticals (TELO) United States $0.201B 0.00
Zevra Therapeutics (ZVRA) United States $0.196B 0.00
Profound Medical (PROF) Canada $0.196B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.193B 0.00
Acrivon Therapeutics (ACRV) United States $0.192B 0.00
MediWound (MDWD) Israel $0.168B 0.00
Achieve Life Sciences (ACHV) Canada $0.157B 0.00
Regulus Therapeutics (RGLS) United States $0.149B 0.00
Incannex Healthcare (IXHL) Australia $0.146B 0.00
CytoDyn (CYDY) United States $0.145B 0.00
Elite Pharmaceuticals (ELTP) United States $0.138B 12.95
Cardiol Therapeutics (CRDL) Canada $0.126B 0.00
Karyopharm Therapeutics (KPTI) United States $0.123B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.121B 2.54
Citius Pharmaceuticals (CTXR) United States $0.117B 0.00
VAXART, INC (VXRT) United States $0.116B 0.00
Relmada Therapeutics (RLMD) United States $0.112B 0.00
Inotiv (NOTV) United States $0.111B 0.00
GlycoMimetics (GLYC) United States $0.110B 0.00
OptiNose (OPTN) United States $0.102B 0.00
FibroGen (FGEN) United States $0.101B 0.00
Eliem Therapeutics (ELYM) United States $0.094B 0.00
Vivani Medical (VANI) United States $0.093B 0.00
AlloVir (ALVR) United States $0.092B 0.00
ProPhase Labs (PRPH) United States $0.089B 0.00
PMV Pharmaceuticals (PMVP) United States $0.088B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.084B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.083B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.078B 0.00
Tempest Therapeutics (TPST) United States $0.077B 0.00
Assertio Holdings (ASRT) United States $0.075B 6.04
Journey Medical (DERM) United States $0.070B 0.00
Champions Oncology (CSBR) United States $0.069B 0.00
Carisma Therapeutics (CARM) United States $0.068B 0.00
Mural Oncology (MURA) Ireland $0.060B 0.00
SCYNEXIS (SCYX) United States $0.056B 0.83
Reneo Pharmaceuticals (RPHM) United States $0.055B 0.00
Gain Therapeutics (GANX) United States $0.050B 0.00
Jaguar Animal Health (JAGX) United States $0.047B 0.00
BioLineRx (BLRX) Israel $0.046B 0.00
Rafael Holdings (RFL) United States $0.042B 0.00
JanOne (JAN) United States $0.040B 0.00
Natural Alternatives (NAII) United States $0.039B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.039B 0.00
Protara Therapeutics (TARA) United States $0.035B 0.00
VYNE Therapeutics (VYNE) United States $0.035B 0.00
ElectroCore (ECOR) United States $0.034B 0.00
Unicycive Therapeutics (UNCY) United States $0.034B 0.00
Viracta Therapeutics (VIRX) United States $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.031B 0.00
CASI Pharmaceuticals (CASI) China $0.031B 0.00
Nutriband (NTRB) United States $0.029B 0.00
DURECT (DRRX) United States $0.028B 0.00
Surrozen (SRZN) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Lipocine (LPCN) United States $0.024B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.024B 11.33
PolyPid (PYPD) Israel $0.023B 0.00
Oncternal Therapeutics (ONCT) United States $0.022B 0.00
TherapeuticsMD (TXMD) United States $0.022B 0.00
CERo Therapeutics Holdings (CERO) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.021B 1.04
Aptorum Group (APM) United Kingdom $0.020B 0.00
BioVie (BIVI) United States $0.020B 0.00
Talphera (TLPH) United States $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.019B 0.00
Alaunos Therapeutics (TCRT) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Addex Therapeutics (ADXN) Switzerland $0.016B 0.00
Dominari Holdings (DOMH) United States $0.016B 0.00
Mannatech (MTEX) United States $0.016B 0.00
Avalo Therapeutics (AVTX) United States $0.015B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.014B 0.00
Traws Pharma (TRAW) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.013B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.013B 0.00
Redhill Biopharma (RDHL) Israel $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.012B 0.00
Biomerica (BMRA) United States $0.011B 0.00
Cosmos Health (COSM) Greece $0.009B 0.00
Molecular Templates (MTEM) United States $0.009B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Plus Therapeutics (PSTV) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.007B 0.00
Clever Leaves Holdings (CLVR) Canada $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Avenue Therapeutics (ATXI) United States $0.005B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
Acutus Medical (AFIB) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
TransCode Therapeutics (RNAZ) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.24
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 44.39